According to the above data, the selective agonists of the GABA-A receptor complex are the drugs of first choice in the drug treatment of insomnia. [22] Once treatment has started, monitoring and ...
Eisai has launched its insomnia drug Dayvigo in Japan, the second in a new class of medicines after Merck & Co’s Belsomra, which made its debut there in 2014. Dayvigo (lemborexant) is a dual ...
Idorsia has become the first drugmaker in the EU to claim approval for a drug for chronic insomnia in the dual orexin receptor antagonist class, ahead of rival drugs from Merck & Co and Eisai.
Seltorexant "is unique," as there are currently no other antidepressants or insomnia therapies with the same mechanism of action, said Krystal, adding that if the FDA approves the drug ...
As with other drugs, Wakix can cause side effects, such as insomnia and nausea. Wakix can cause certain side effects, some of which are more common than others. These side effects may be temporary ...